167 related articles for article (PubMed ID: 17061699)
1. [Efficacy of intravenous immunoglobulin for slowly progressive cerebellar atrophy].
Takeguchi M; Nanri K; Okita M; Taguchi T; Ishiko T; Saitoh H
Rinsho Shinkeigaku; 2006 Jul; 46(7):467-74. PubMed ID: 17061699
[TBL] [Abstract][Full Text] [Related]
2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
4. [Case of anti-TPO/gliadin antibody-positive cerebellar atrophy that responded to intravenous immunoglobulin therapy begun 16 years after onset].
Tanaka N; Otake H; Ito S; Niiyama K; Nanri K
Rinsho Shinkeigaku; 2012; 52(5):351-5. PubMed ID: 22688115
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
[TBL] [Abstract][Full Text] [Related]
6. Distribution of cerebello-olivary degeneration in idiopathic late cortical cerebellar atrophy: clinicopathological study of four autopsy cases.
Ota S; Tsuchiya K; Anno M; Niizato K; Akiyama H
Neuropathology; 2008 Feb; 28(1):43-50. PubMed ID: 18181834
[TBL] [Abstract][Full Text] [Related]
7. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
[TBL] [Abstract][Full Text] [Related]
8. Gluten sensitivity in sporadic and hereditary cerebellar ataxia.
Bushara KO; Goebel SU; Shill H; Goldfarb LG; Hallett M
Ann Neurol; 2001 Apr; 49(4):540-3. PubMed ID: 11310636
[TBL] [Abstract][Full Text] [Related]
9. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
[TBL] [Abstract][Full Text] [Related]
10. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.
Taniguchi Y; Tanji C; Kawai T; Saito H; Marubayashi S; Yorioka N
Ther Apher Dial; 2006 Feb; 10(1):90-3. PubMed ID: 16556143
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
[TBL] [Abstract][Full Text] [Related]
12. Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia.
Le Ber I; Clot F; Vercueil L; Camuzat A; Viémont M; Benamar N; De Liège P; Ouvrard-Hernandez AM; Pollak P; Stevanin G; Brice A; Dürr A
Neurology; 2006 Nov; 67(10):1769-73. PubMed ID: 17130408
[TBL] [Abstract][Full Text] [Related]
13. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic cerebellar degeneration with asymmetrical pan-cerebellar syndrome].
Porta-Etessam J; Berbel A; Martínez-Salio A; Benito-León J; Pitarch D; Molina JA; Bermejo F
Rev Neurol; 1998 Jun; 26(154):1015-7. PubMed ID: 9658484
[TBL] [Abstract][Full Text] [Related]
16. [Cortical cerebellar atrophy presenting with central type sleep apnea syndrome].
Qingyu J; Nomura T; Ochi H; Taniwaki T; Furuya H; Kira J
Rinsho Shinkeigaku; 2005 Jul; 45(7):490-4. PubMed ID: 16119830
[TBL] [Abstract][Full Text] [Related]
17. [Late cerebellar ataxia associated with fragile X premutation].
Chaussenot A; Borg M; Bayreuther C; Lebrun C
Rev Neurol (Paris); 2008 Nov; 164(11):957-63. PubMed ID: 18808779
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
19. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
Petrijan T; Menih M
Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
[TBL] [Abstract][Full Text] [Related]
20. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
